TLR9 and diffuse large B-cell lymphoma: Using the TLR9 inhibitor at concentrations of 10 μΜ and 20 μΜ resulted in a significant, concentration-dependent decrease in cell growth in DLBCL cell lines of ABC type (U2932, OCI-LY3) but not in those of GCB type (MS, RCK8) (Figure S6).